Agilent Technologies Inc Total Liabilities
Agilent Technologies Inc total liabilities. Based on the latest financial reports, Agilent Technologies Inc (A) has total liabilities worth $5.99 Billion USD as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Agilent Technologies Inc (A) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Agilent Technologies Inc (1998–2025)
Total liabilities of Agilent Technologies Inc from 1998 to 2025. This chart illustrates how Agilent Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Agilent Technologies Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Agilent Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Agilent Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DR Horton Inc
NYSE:DHI
|
USA | $10.08 Billion |
|
Ferguson Plc
NYSE:FERG
|
USA | $11.91 Billion |
|
MSCI Inc
NYSE:MSCI
|
USA | $8.32 Billion |
|
Humana Inc
NYSE:HUM
|
USA | $37.92 Billion |
|
Coca-Cola European Partners PLC
NASDAQ:CCEP
|
USA | $23.28 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €7.76 Trillion |
|
East Money Information Co Ltd
SHE:300059
|
China | CN¥344.29 Billion |
|
STANDARD CHART.UNSP.ADR/2
F:STD0
|
Germany | €918.22 Billion |
Liability Composition Analysis (1998–2025)
This chart breaks down Agilent Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see A total assets.
Liquidity & Leverage Metrics
Agilent Technologies Inc Total Liabilities Ratios Explained
Agilent Technologies Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Agilent Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Agilent Technologies Inc (1998–2025)
The table below shows the annual total liabilities of Agilent Technologies Inc from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-10-31 | $5.99 Billion | +0.64% |
| 2024-10-31 | $5.95 Billion | +20.94% |
| 2023-10-31 | $4.92 Billion | -5.91% |
| 2022-10-31 | $5.23 Billion | -1.67% |
| 2021-10-31 | $5.32 Billion | +11.82% |
| 2020-10-31 | $4.75 Billion | +1.06% |
| 2019-10-31 | $4.70 Billion | +18.49% |
| 2018-10-31 | $3.97 Billion | +10.55% |
| 2017-10-31 | $3.59 Billion | +0.50% |
| 2016-10-31 | $3.57 Billion | +7.69% |
| 2015-10-31 | $3.32 Billion | -39.38% |
| 2014-10-31 | $5.47 Billion | +1.41% |
| 2013-10-31 | $5.40 Billion | +0.86% |
| 2012-10-31 | $5.35 Billion | +12.87% |
| 2011-10-31 | $4.74 Billion | -26.61% |
| 2010-10-31 | $6.46 Billion | +26.52% |
| 2009-10-31 | $5.11 Billion | +4.67% |
| 2008-10-31 | $4.88 Billion | +12.92% |
| 2007-10-31 | $4.32 Billion | +16.44% |
| 2006-10-31 | $3.71 Billion | +38.95% |
| 2005-10-31 | $2.67 Billion | -23.43% |
| 2004-10-31 | $3.49 Billion | +0.40% |
| 2003-10-31 | $3.47 Billion | -2.88% |
| 2002-10-31 | $3.58 Billion | +53.67% |
| 2001-10-31 | $2.33 Billion | -24.08% |
| 2000-10-31 | $3.06 Billion | +48.64% |
| 1999-10-31 | $2.06 Billion | +4.94% |
| 1998-10-31 | $1.97 Billion | -- |
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more